• No results found

Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn’s disease

N/A
N/A
Protected

Academic year: 2020

Share "Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn’s disease"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1 CD68 staining macrophages (red) can be seen to contain E. coli ( blue ) in the biopsy from a patient with CD ((a) low power (x40), (b) highpower (x63), but not in biopsies from a healthy control (x20) (c)
Table 1 Oligonucleotide primer pairs used for RT-qPCR analysis
Table 3 Biopsy site and proportion of subjects with E. coli-ladenmacrophages
Fig. 2 Higher median endoscopic severity score for CD patientswith E. coli-laden LP macrophages compared with those withoutE
+3

References

Related documents

One di ffi culty that we face when taking this model to the data is that changes in housing demand for a particular country are not directly observable. In particular, the

We developed ChildServ in Hartford on the as- sumptions that children with developmental and be- havioral problems were eluding early detection; that many initiatives existed to

It can only be stated that, for the Hamilton (CMA) the compact urban form leads to congestion and nitrogen oxide levels which are significantly lower than the magnitudes of

CHL: Classical Hodgkin lymphoma; DLBCL: Diffuse large B cell lymphoma; EBER: EBV-associated small RNAs; FL: Follicular lymphoma; HPF: High-power fields; ISH: In situ hybridization;

A correlation between topo II gene expression and sensitivity to doxorubicin, etoposide and cisplatin was also found in lung cancer cell lines not selected in vitro for

The present study investigated the effect of processing regular and irregular word morphology on L2 vocabulary learning amongst low-level native Arabic learners

This hermeneutic phenomenological study uncovers meanings associated with the lived experience of risk, or the ‘not taking’ of risk following a recent diagnosis of

The success of this model depends on achieving large returns from a small number of drugs in order to pay for the high cost of the drug discovery and development process for a